Your browser doesn't support javascript.
loading
Primary gastrointestinal anaplastic large cell lymphoma.
Lee, Yi-Ying; Takata, Katsuyoshi; Wang, Ren-Ching; Yang, Sheau-Fang; Chuang, Shih-Sung.
Afiliação
  • Lee YY; Department of Pathology, Chi-Mei Medical Center, Liouying, Taiwan.
  • Takata K; Department of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Wang RC; Department of Pathology and Laboratory Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
  • Yang SF; Department of Pathology, Kaohsiung Medical University Hospital and School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Chuang SS; Department of Pathology, Chi-Mei Medical Center, Tainan, Taiwan; Department of Pathology, Taipei Medical University, Taipei, Taiwan; Department of Pathology, National Taiwan University, Taipei, Taiwan. Electronic address: cmh5301@mail.chimei.org.tw.
Pathology ; 49(5): 479-485, 2017 Aug.
Article em En | MEDLINE | ID: mdl-28693749
ABSTRACT
Primary gastrointestinal anaplastic large cell lymphoma (GI-ALCL) is rare. We report eight new cases. The median age was 61.5 years (range 10-88), most frequently involving the stomach (n = 3) and small intestine (n = 4). The neoplastic hallmark cells in all cases expressed CD30. Anaplastic lymphoma kinase (ALK) protein was expressed in two cases (25%). By in situ hybridisation, all cases were negative for Epstein-Barr virus and for DUSP22/IRF4 gene translocation. At a median follow-up time of 37.5 months, four patients died of disease, one was alive with disease, and three were disease-free. Our literature review showed that GI-ALCL occurred mainly in older patients and was characterised by a low rate of ALK expression, a high rate of T-cell lineage, and a frequent occurrence in the small intestine. Incorporating our two ALK+ GI-ALCL cases together with the four cases in the literature, the median age was 34 years (range 10-56), with four (67%) cases in the small intestine. The six patients were all alive with a median follow-up of 21 months. The 5-year overall survival of our six patients with ALK- GI-ALCL was 40%, in contrast to 100% with ALK+ GI-ALCL. The prognosis for ALK- GI-ALCL was poor, while that for the ALK+ counterparts was good.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Células T Periférico / Receptores Proteína Tirosina Quinases / Linfoma Anaplásico de Células Grandes / Neoplasias Gastrointestinais Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Humans / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Células T Periférico / Receptores Proteína Tirosina Quinases / Linfoma Anaplásico de Células Grandes / Neoplasias Gastrointestinais Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Humans / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article